The expression of GTF3C2 in HCC and non-tumor tissues, along with its clinical significance, was investigated using public databases and clinical samples. Reverse transcription-quantitative ...

triggering oncogene expression that drives tumor growth. Significantly, the researchers found that PDHX acetylation is upregulated in HCC tissues and correlates with poor clinical prognosis.